ExCap's THE RISING Series: Joseph Payne, CEO Arcturus Therapeutics (ARCT),
Excelsior Capital Partners' THE RISING
0:00 / 0:00
ExCap's THE RISING Series: Joseph Payne, CEO Arcturus Therapeutics (ARCT),
266 просмотров · 12 дн. назад
Excelsior Capital Partners' THE RISING
50 подписчиков
266 просмотров · 12 дн. назад
Joe explains to Jim how ARCT's messenger RNA (mRNA) tech--for which ARCT holds 500+ patents--gives it 3 Shots on Goal:
--liver
--lung
--vaccines
